Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | UTHR | CORT | ||
| Company | Neurocrine Bioscienc | United Therapeutic | Corcept Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 153.13 | 523.23 | 121.48 | ||
| High | 155.26 | 528.02 | 123.44 | ||
| Low | 152.51 | 512.29 | 120.56 | ||
| Last | 152.57 | 513.12 | 122.25 | ||
| Change | -0.36 | -7.88 | +1.20 | ||
| Percent Change | -0.24% | -1.51% | +0.99% | ||
| Volume | 1,227,600 | 415,500 | 656,400 | ||
| 20-Day Average Volume | 1,460,925 | 536,085 | 1,160,045 | ||
| Previous | 152.93 | 521.00 | 121.05 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 163.30 | 519.67 | 111.20 | ||
| 20-Day Raw Stochastic | 10.16% | 44.44% | 96.45% | ||
| 20-Day Relative Strength | 40.14 | 44.18 | 69.94 | ||
| Weighted Alpha | +11.36 | +34.18 | +256.90 | ||
| Today's Opinion | 24% Buy | 72% Sell | 100% Buy | ||
| Yesterday's Opinion | 24% Buy | 24% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.10% since 08/14/26 | +2.68% since 08/14/26 | +6.80% since 08/14/26 | ||
| Low | 150.69 on 08/17/26 | 499.96 on 08/17/26 | 114.39 on 08/17/26 | ||
| High | 156.55 on 08/19/26 | 535.77 on 08/19/26 | 123.44 on 08/21/26 | ||
| 1-Month | |||||
| %Chg | -14.79% since 07/21/26 | -4.24% since 07/21/26 | +27.81% since 07/21/26 | ||
| Low | 148.77 on 08/14/26 | 490.80 on 08/05/26 | 90.00 on 07/28/26 | ||
| High | 186.12 on 07/30/26 | 541.25 on 07/22/26 | 123.44 on 08/21/26 | ||
| 3-Month | |||||
| %Chg | -1.88% since 05/21/26 | -9.32% since 05/21/26 | +104.81% since 05/21/26 | ||
| Low | 148.77 on 08/14/26 | 490.80 on 08/05/26 | 59.03 on 05/26/26 | ||
| High | 186.12 on 07/30/26 | 580.39 on 05/27/26 | 123.44 on 08/21/26 | ||
| 6-Month | |||||
| %Chg | +18.61% since 02/20/26 | +8.39% since 02/20/26 | +251.09% since 02/20/26 | ||
| Low | 125.11 on 03/24/26 | 466.00 on 02/23/26 | 31.81 on 03/13/26 | ||
| High | 186.12 on 07/30/26 | 609.35 on 05/06/26 | 123.44 on 08/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,508,589 | 22,008,224 | 13,214,980 | ||
| Shares Outstanding, K | 101,649 | 42,891 | 108,098 | ||
| Annual Sales, $M | 2,860,500,000 | 3,182,700,000 | 761,410,000 | ||
| Annual Net Income, $M | 478,600,000 | 1,334,700,000 | 99,650,000 | ||
| Last Qtr Sales, $M | 959,000,000 | 783,300,000 | 256,150,000 | ||
| Last Qtr Income, $M | 144,400,000 | 333,000,000 | 42,990,000 | ||
| 60-Month Beta | 0.39 | 0.59 | 0.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.85 on 07/30/26 | 7.27 on 08/05/26 | 0.36 on 07/29/26 | ||
| Latest Earnings Date | 10/27/26 | 11/04/26 | 11/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 21.12 | 18.64 | 288.21 | ||